1.1. Research Objective

1.2. Product Type Overview

1.3. Market Segmentation

2.1. Qualitative Research
2.1.1. Primary & Secondary Sources

2.2. Quantitative Research
2.2.1. Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.4. Assumption for the Study

2.5. Market Size Estimation

2.6. Data Triangulation

Executive Summary: Europe In Vitro Diagnostics Market 

4.1. Industry Value Chain Analysis
4.1.1. Material Provider
4.1.2. Manufacturer
4.1.3. Service Provider
4.1.4. End User

4.2. Industry Outlook
4.2.1. In Vitro Diagnostic (IVD) Regulation in Europe 
4.2.2. In Vitro Diagnostics Development and Clinical Trials 

4.3. PESTLE Analysis

4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition

4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Challenges
4.5.4. Key Trends

4.6. Covid-19 Impact Assessment on Market Growth Trend

4.7. Market Growth and Outlook
4.7.1. Market Revenue Estimates and Forecast (US$ Bn), 2019 - 2032
4.7.2. Price Trend Analysis, By Product

4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2023
4.8.3. Competitor Mapping

5.1. Key Insights

5.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
5.2.1. Reagents
5.2.2. Instruments
5.2.3. Software
5.2.4. Services

6.1. Key Insights

6.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
6.2.1. Immunodiagnostics
6.2.2. Hematology
6.2.3. Molecular Diagnostics
6.2.4. Tissue Diagnostics
6.2.5. Clinical Chemistry
6.2.6. Others

7.1. Key Insights

7.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
7.2.1. Cancer diagnostics
7.2.2. Blood glucose monitoring 
7.2.3. Human genetic testing 
7.2.4. Immunoassays
7.2.5. Hepatitis tests
7.2.6. Infectious Diseases diagnostics
7.2.7. Cardiac Diseases
7.2.8. Nephrological Diseases
7.2.9. Gastrointestinal Diseases
7.2.10. Others

8.1. Key Insights

8.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
8.2.1. Standalone Laboratories
8.2.2. Hospitals
8.2.3. Academic And Medical Schools
8.2.4. Point Of Care
8.2.5. Others

9.1. Key Insights

9.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
9.2.1. Western Europe
9.2.1.1. The UK
9.2.1.2. Germany
9.2.1.3. France
9.2.1.4. Italy
9.2.1.5. Spain
9.2.1.6. Rest of Western Europe
9.2.2. Eastern Europe
9.2.2.1. Poland 
9.2.2.2. Russia
9.2.2.3. Rest of Eastern Europe

10.1. Key Insights

10.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
10.2.1. By Product & Services
10.2.2. By Technique
10.2.3. By Application
10.2.4. By End User

11.1. Key Insights

11.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
11.2.1. By Product & Services
11.2.2. By Technique
11.2.3. By Application
11.2.4. By End User

12.1. Key Insights

12.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
12.2.1. By Product & Services
12.2.2. By Technique
12.2.3. By Application
12.2.4. By End User

13.1. Key Insights

13.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
13.2.1. By Product & Services
13.2.2. By Technique
13.2.3. By Application
13.2.4. By End User

14.1. Key Insights

14.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
14.2.1. By Product & Services
14.2.2. By Technique
14.2.3. By Application
14.2.4. By End User

15.1. Key Insights

15.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
15.2.1. By Product & Services
15.2.2. By Technique
15.2.3. By Application
15.2.4. By End User

16.1. Key Insights

16.2. Market Size and Forecast, 2019 - 2032 (US$ Bn)
16.2.1. By Product & Services
16.2.2. By Technique
16.2.3. By Application
16.2.4. By End User

17.1. Abbott
17.2. Agilent Technologies, Inc.
17.3. Becton Dickinson and Company
17.4. bioMérieux SA
17.5. Bio-Rad Laboratories, Inc.
17.6. Charles River Laboratories
17.7. Danaher Corporation
17.8. F. Hoffmann-La Roche Ltd.
17.9. Qiagen
17.10. Quest Diagnostics
17.11. Quidel Corp.
17.12. Siemens Healthineers
17.13. Sysmex Corp.
17.14. Other Prominent Players